Racial and Ethnic Inequities in Diabetes Pharmacotherapy: Black and Hispanic Patients Are Less Likely to Receive SGLT2is and GLP1as

J Gen Intern Med. 2022 Oct;37(13):3501-3503. doi: 10.1007/s11606-022-07428-1. Epub 2022 Feb 9.
No abstract available

MeSH terms

  • Black People
  • Black or African American
  • Diabetes Mellitus* / drug therapy
  • Diabetes Mellitus* / epidemiology
  • Ethnicity
  • Hispanic or Latino*
  • Humans
  • Racial Groups
  • United States